Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 10/2021

01-10-2021 | Human Immunodeficiency Virus | Original Paper

Correlates of PrEP Uptake Among Young Sexual Minority Men and Transgender Women in New York City: The Need to Reframe “Risk” Messaging and Normalize Preventative Health

Authors: J. Jaiswal, C. LoSchiavo, S. Meanley, K. Hascher, A. B. Cox, K. B. Dunlap, S. N. Singer, P. N. Halkitis

Published in: AIDS and Behavior | Issue 10/2021

Login to get access

Abstract

Pre-exposure prophylaxis (PrEP) is an effective form of HIV prevention, but young sexual minority men face myriad barriers to PrEP uptake. Participants (n = 202) completed a survey on healthcare experiences and beliefs about HIV and PrEP. While 98% of the sample knew about PrEP, only 23.2% reported currently taking PrEP. Participants were more likely to be taking PrEP if they received PrEP information from a healthcare provider and endorsed STI-related risk compensation. Conversely, PrEP uptake was less likely among those with concerns about medication use and adherence. While there were no racial/ethnic differences in PrEP uptake, there were differences in correlates of PrEP use for White participants and participants of color. To facilitate PrEP uptake, clinicians should provide PrEP education and screen all patients for PrEP candidacy. Additionally, public health messaging must reframe HIV “risk”, highlight benefits of STI testing, and emphasize the importance of preventive healthcare for SMM.
Appendix
Available only for authorised users
Literature
1.
2.
Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.PubMedPubMedCentralCrossRef
3.
4.
5.
Baral SD, Poteat T, Strömdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214–22.PubMedCrossRef
6.
D’Avanzo PA, Bass SB, Brajuha J, Gutierrez-Mock L, Ventriglia N, Wellington C, et al. Medical mistrust and PrEP perceptions among transgender women: a cluster analysis. Behav Med. 2019;45(2):143–52.PubMedCrossRef
7.
Thomann M, Grosso A, Zapata R, Chiasson MA. ‘WTF is PrEP?’: attitudes towards pre-exposure prophylaxis among men who have sex with men and transgender women in New York City. Cult Heal Sex. 2018;20(7):772–86.CrossRef
8.
Centers for Disease Control and Prevention. HIV prevention pill not reaching most Americans who could benefit—especially people of color. Atlanta: Centers for Disease Control and Prevention; 2018.
9.
Finlayson T, Cha S, Xia M, Trujillo L, Denson D, Prejean J, et al. Changes in HIV preexposure prophylaxis awareness and use among men who have sex with men—20 urban areas, 2014 and 2017. Morb Mortal Wkly Rep [Internet]. 2019;68:597.CrossRef
10.
Frazer E, Mitchell RA Jr, Nesbitt LS, Williams M, Mitchell EP, Williams RA, et al. The violence epidemic in the African American community: a call by the National Medical Association for comprehensive reform. J Natl Med Assoc. 2018;110(1):4–15.PubMed
11.
Bogart LM, Dale SK, Christian J, Patel K, Daffin GK, Mayer KH, et al. Coping with discrimination among HIV-positive Black men who have sex with men. Cult Health Sex. 2017;19(7):723–37.PubMedCrossRef
12.
Wood S, Gross R, Shea JA, Bauermeister JA, Franklin J, Petsis D, et al. Barriers and facilitators of PrEP adherence for young men and transgender women of color. AIDS Behav. 2019;23(10):2719–29.PubMedPubMedCentralCrossRef
13.
Cahill S, Taylor SW, Elsesser SA, Mena L, Hickson D, Mayer KH. Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts. AIDS Care. 2017;29(11):1351–8.PubMedPubMedCentralCrossRef
14.
Griffin M, Jaiswal J, King D, Singer SN, Halkitis PN. Sexuality disclosure, trust, and satisfaction with primary care among urban young adult sexual minority men. J Nurse Pract. 2020;16:378–87.CrossRef
15.
Knight RE, Shoveller JA, Carson AM, Contreras-Whitney JG. Examining clinicians’ experiences providing sexual health services for LGBTQ youth: considering social and structural determinants of health in clinical practice. Health Educ Res. 2014;29(4):662–70.PubMedPubMedCentralCrossRef
16.
Wylie K, Knudson G, Khan SI, Bonierbale M, Watanyusakul S, Baral S. Serving transgender people: clinical care considerations and service delivery models in transgender health. Lancet. 2016;388(10042):401–11.PubMedCrossRef
17.
Wamsley L. California to make HIV prevention drugs available without a prescription. Guam: National Public Radio; 2019.
18.
19.
Blumenthal J, Jain S, Krakower D, Sun X, Young J, Mayer K, et al. Knowledge is power! Increased provider knowledge scores regarding pre-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescribe PrEP. AIDS Behav. 2015;19(5):802–10.PubMedPubMedCentralCrossRef
20.
Seidman D, Carlson K, Weber S, Newmann S, Witt J. Family planning providers’ knowledge of and attitudes toward preexposure prophylaxis for HIV prevention: a national survey. Contraception. 2015;92(4):411.CrossRef
21.
Turner L, Roepke A, Wardell E, Teitelman AM. Do you PrEP? A review of primary care provider knowledge of PrEP and attitudes on prescribing PrEP. J Assoc Nurses AIDS Care. 2018;29(1):83–92.PubMedCrossRef
22.
Fallon SA, Park JN, Ogbue CP, Flynn C, German D. Awareness and acceptability of pre-exposure HIV prophylaxis among men who have sex with men in Baltimore. AIDS Behav. 2017;21(5):1268–77.PubMedCrossRef
23.
Hoffman S, Guidry JA, Collier KL, Mantell JE, Boccher-Lattimore D, Kaighobadi F, et al. A clinical home for preexposure prophylaxis: diverse health care providers’ perspectives on the “purview paradox.” J Int Assoc Provid AIDS Care. 2016;15(1):59–65.PubMedCrossRef
24.
Silapaswan A, Krakower D, Mayer KH. Pre-exposure prophylaxis: a narrative review of provider behavior and interventions to increase PrEP implementation in primary care. J Gen Intern Med. 2017;32(2):192–8.PubMedCrossRef
25.
Calabrese SK, Magnus M, Mayer KH, Krakower DS, Eldahan AI, Hawkins LAG, et al. “Support your client at the space that they’re in”: HIV pre-exposure prophylaxis (PrEP) prescribers’ perspectives on PrEP-related risk compensation. AIDS Patient Care STDS. 2017;31(4):196–204.PubMedPubMedCentralCrossRef
26.
Newcomb ME, Moran K, Feinstein BA, Forscher E, Mustanski B. Pre-exposure prophylaxis (PrEP) use and condomless anal sex: evidence of risk compensation in a cohort of young men who have sex with men. J Acquir Immune Defic Syndr. 2018;77(4):358.PubMedPubMedCentralCrossRef
27.
Storholm ED, Volk JE, Marcus JL, Silverberg MJ, Satre DD. Risk perception, sexual behaviors, and PrEP adherence among substance-using men who have sex with men: a qualitative study. Prev Sci. 2017;18(6):737–47.PubMedPubMedCentralCrossRef
28.
Hojilla JC, Koester KA, Cohen SE, Buchbinder S, Ladzekpo D, Matheson T, et al. Sexual behavior, risk compensation, and HIV prevention strategies among participants in the San Francisco PrEP demonstration project: a qualitative analysis of counseling notes. AIDS Behav. 2016;20(7):1461–9.PubMedCentralCrossRef
29.
Grov C, Whitfield THF, Rendina HJ, Ventuneac A, Parsons JT. Willingness to take PrEP and potential for risk compensation among highly sexually active gay and bisexual men. AIDS Behav. 2015;19(12):2234–44.PubMedPubMedCentralCrossRef
30.
Gafos M, Horne R, Nutland W, Bell G, Rae C, Wayal S, et al. The context of sexual risk behaviour among men who have sex with men seeking PrEP, and the impact of PrEP on sexual behaviour. AIDS Behav. 2019;23(7):1708–20.PubMedCrossRef
31.
Hoff CC, Chakravarty D, Bircher AE, Campbell CK, Grisham K, Neilands TB, et al. Attitudes towards PrEP and anticipated condom use among concordant HIV-negative and HIV-discordant male couples. AIDS Patient Care STDS. 2015;29(7):408–17.PubMedPubMedCentralCrossRef
32.
Quinn K, Dickson-Gomez J, Zarwell M, Pearson B, Lewis M. “A gay man and a doctor are just like, a recipe for destruction”: how racism and homonegativity in healthcare settings influence PrEP uptake among young black MSM. AIDS Behav. 2019;23(7):1951–63.PubMedPubMedCentralCrossRef
33.
Olansky E, Mansergh G, Pitts N, Mimiaga MJ, Denson DJ, Landers S, et al. PrEP awareness in the context of HIV/AIDS conspiracy beliefs among Black/African American and Hispanic/Latino MSM in three urban US cities. J Homosex. 2020;67(6):833–43.PubMedCrossRef
34.
Ojikutu BO, Amutah-Onukagha N, Mahoney TF, Tibbitt C, Dale SD, Mayer KH, et al. HIV-related mistrust (or HIV conspiracy theories) and willingness to use PrEP among black women in the United States. AIDS Behav. 2020;24:2927.PubMedCrossRefPubMedCentral
35.
Eaton LA, Driffin DD, Kegler C, Smith H, Conway-Washington C, White D, et al. The role of stigma and medical mistrust in the routine health care engagement of black men who have sex with men. Am J Public Health [Internet]. 2015;105(2):e75-82.CrossRef
36.
37.
Halkitis P, Kapadia F, Ompad D. Incidence of HIV infection in young gay, bisexual, and other YMSM: the P18 Cohort Study. J Acquir Immune Defic Syndr. 2015;69(4):466.PubMedPubMedCentralCrossRef
38.
Halkitis PN, Moeller RW, Siconolfi DE, Storholm ED, Solomon TM, Bub KL. Measurement model exploring a syndemic in emerging adult gay and bisexual men. AIDS Behav. 2013;17(2):662–73.PubMedPubMedCentralCrossRef
39.
Halkitis PN, Kapadia F, Bub KL, Barton S, Moreira AD, Stults CB. A longitudinal investigation of syndemic conditions among young gay, bisexual, and other MSM: the P18 Cohort Study. AIDS Behav. 2015;19(6):970–80.PubMedPubMedCentralCrossRef
40.
Bogart LM, Thorburn S. Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans? JAIDS J Acquir Immune Defic Syndr. 2005;38(2):213–8.PubMedCrossRef
41.
Thompson HS, Valdimarsdottir HB, Winkel G, Jandorf L, Redd W. The Group-Based Medical Mistrust Scale: psychometric properties and association with breast cancer screening. Prev Med (Baltim). 2004;38(2):209–18.CrossRef
42.
Anderson LA, Dedrick RF. Development of the Trust in Physician scale: a measure to assess interpersonal trust in patient-physician relationships. Psychol Rep. 1990;67(3):1091–100.PubMed
43.
LaVeist TA, Isaac LA, Williams KP. Mistrust of health care organizations is associated with underutilization of health services. Health Serv Res. 2009;44(6):2093–105.PubMedPubMedCentralCrossRef
44.
Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Heal. 1999;14(1):1–24.CrossRef
45.
Rael CT, Martinez M, Giguere R, Bockting W, MacCrate C, Mellman W, et al. Barriers and facilitators to oral PrEP use among transgender women in New York City. AIDS Behav. 2018;22(11):3627–36.PubMedPubMedCentralCrossRef
46.
Koechlin FM, Fonner VA, Dalglish SL, O’Reilly KR, Baggaley R, Grant RM, et al. Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: a systematic review of the literature. AIDS Behav. 2017;21(5):1325–35.PubMedCrossRef
47.
Franks J, Hirsch-Moverman Y, Loquere AS, Amico KR, Grant RM, Dye BJ, et al. Sex, PrEP, and stigma: experiences with HIV pre-exposure prophylaxis among New York City MSM participating in the HPTN 067/ADAPT Study. AIDS Behav. 2018;22(4):1139–49.PubMedCrossRef
48.
John SA, Whitfield THF, Rendina HJ, Parsons JT, Grov C. Will gay and bisexual men taking oral pre-exposure prophylaxis (PrEP) switch to long-acting injectable PrEP should it become available? AIDS Behav. 2018;22(4):1184–9.PubMedPubMedCentralCrossRef
49.
Freeborn K, Portillo CJ. Does pre-exposure prophylaxis for HIV prevention in men who have sex with men change risk behaviour? A systematic review. J Clin Nurs. 2018;27(17–18):3254–65.PubMedPubMedCentralCrossRef
50.
Morgan E, Dyar C, Newcomb ME, Richard TD, Mustanski B. PrEP use and sexually transmitted infections are not associated longitudinally in a cohort study of young men who have sex with men and transgender women in Chicago. AIDS Behav. 2019;24:1334.CrossRef
51.
Stenger MR, Baral S, Stahlman S, Wohlfeiler D, Barton JE, Peterman T. As through a glass, darkly: the future of sexually transmissible infections among gay, bisexual and other men who have sex with men. Sex Health. 2017;14(1):18–27.PubMedPubMedCentralCrossRef
52.
Scott HM, Klausner JD. Sexually transmitted infections and pre-exposure prophylaxis: challenges and opportunities among men who have sex with men in the US. AIDS Res Ther. 2016;13(1):5.PubMedPubMedCentralCrossRef
53.
Traeger MW, Cornelisse VJ, Asselin J, Price B, Roth NJ, Willcox J, et al. Association of HIV preexposure prophylaxis with incidence of sexually transmitted infections among individuals at high risk of HIV infection. JAMA. 2019;321(14):1380–90.PubMedPubMedCentralCrossRef
54.
Walker D, Friderici J, Skiest D. Primary care providers have limited knowledge about STI screening and HIV PrEP in men who have sex with men. Open Forum Infect Dis. 2017;4:S667.PubMedCentralCrossRef
55.
Hightow-Weidman LB, Magnus M, Beauchamp G, Hurt CB, Shoptaw S, Emel L, et al. Incidence and correlates of sexually transmitted infections among black men who have sex with men participating in the HIV prevention trials network 073 preexposure prophylaxis study. Clin Infect Dis. 2019;69(9):1597–604.PubMedPubMedCentralCrossRef
56.
Calabrese SK, Krakower DS, Mayer KH. Integrating HIV preexposure prophylaxis (PrEP) into routine preventive health care to avoid exacerbating disparities. Am J Public Health. 2017;107(12):1883–9.PubMedPubMedCentralCrossRef
57.
Pleuhs B, Quinn KG, Walsh JL, Petroll AE, John SA. Health care provider barriers to HIV pre-exposure prophylaxis in the United States: a systematic review. AIDS Patient Care STDS. 2020;34(3):111–23.PubMedPubMedCentralCrossRef
58.
Carter MR, Aaron E, Nassau T, Brady KA. Knowledge, attitudes, and PrEP prescribing practices of health care providers in Philadelphia, PA. J Prim Care Community Heal. 2019;10:215013271987852.CrossRef
59.
Tellalian D, Maznavi K, Bredeek UF, Hardy WD. Pre-exposure prophylaxis (PrEP) for HIV infection: results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices. AIDS Patient Care STDS. 2013;27(10):553–9.PubMedCrossRef
60.
Petroll AE, Walsh JL, Owczarzak JL, McAuliffe TL, Bogart LM, Kelly JA. PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS Behav. 2017;21(5):1256–67.PubMedPubMedCentralCrossRef
61.
Ojile N, Sweet D, Kallail KJ. A preliminary study of the attitudes and barriers of family physicians to prescribing HIV preexposure prophylaxis. Kansas J Med. 2017;10(2):40.CrossRef
62.
Meanley S, Gale A, Harmell C, Jadwin-Cakmak L, Pingel E, Bauermeister JA. The role of provider interactions on comprehensive sexual healthcare among young men who have sex with men. AIDS Educ Prev. 2015;27(1):15–26.PubMedCrossRef
63.
64.
65.
Brooks RA, Landovitz RJ, Regan R, Lee S-J, Allen VC Jr. Perceptions of and intentions to adopt HIV pre-exposure prophylaxis among black men who have sex with men in Los Angeles. Int J STD AIDS. 2015;26(14):1040–8.PubMedPubMedCentralCrossRef
66.
Jaiswal J, LoSchiavo C, Perlman DC. Disinformation, misinformation and inequality-driven mistrust in the time of COVID-19: lessons unlearned from AIDS denialism. AIDS Behav. 2020;24:2776.PubMedCrossRefPubMedCentral
67.
Biello KB, Mimiaga MJ, Santostefano CM, Novak DS, Mayer KH. MSM at highest risk for HIV acquisition express greatest interest and preference for injectable antiretroviral PrEP compared to daily, oral medication. AIDS Behav. 2018;22(4):1158–64.PubMedPubMedCentralCrossRef
68.
69.
Calabrese SK. Understanding, contextualizing, and addressing PrEP stigma to enhance PrEP implementation. Curr HIV/AIDS Rep. 2020;17(6):579–88.PubMedCrossRef
70.
71.
Elsesser SA, Oldenburg CE, Biello KB, Mimiaga MJ, Safren SA, Egan JE, et al. Seasons of risk: anticipated behavior on vacation and interest in episodic antiretroviral pre-exposure prophylaxis (PrEP) among a large national sample of US men who have sex with men (MSM). AIDS Behav. 2016;20(7):1400–7.PubMedPubMedCentralCrossRef
72.
73.
Sevelius JM, Keatley JA, Calma N, Arnold E. ‘I am not a man’: trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016;11(7–8):1060–75.PubMedCrossRef
74.
Conniff J, Evensen A. Preexposure prophylaxis (PrEP) for HIV prevention: the primary care perspective. J Am Board Fam Med. 2016;29(1):143–51.PubMedCrossRef
75.
Card KG, Hawkins BW, Mortazavi L, Gregory A, Ng KH, Lachowsky NJ. Stigma, the media, and pre-exposure prophylaxis for HIV prevention: observations for enhancing knowledge translation and resisting stigma in the Canadian context. AIDS Behav. 2019;23(7):1877–87.PubMedCrossRef
76.
Chávez PRG, Wesolowski LG, Peters PJ, Johnson CH, Nasrullah M, Oraka E, et al. How well are US primary care providers assessing whether their male patients have male sex partners? Prev Med (Baltim). 2018;107:75–80.CrossRef
77.
Fuzzell L, Fedesco HN, Alexander SC, Fortenberry JD, Shields CG. “I just think that doctors need to ask more questions”: sexual minority and majority adolescents’ experiences talking about sexuality with healthcare providers. Patient Educ Couns. 2016;99(9):1467–72.PubMedCrossRef
78.
Halkitis PN, Jaiswal J, Griffin-Tomas M, Krause KD, D’Avanzo P, Kapadia F. Beliefs about the end of AIDS, concerns about PrEP functionality, and perceptions of HIV risk as drivers of PrEP use in urban sexual minority men: the P18 cohort study. AIDS Behav. 2018;22(11):3705–17.PubMedCrossRef
79.
Zhang HL, Rhea SK, Hurt CB, Mobley VL, Swygard H, Seña AC, et al. HIV pre-exposure prophylaxis implementation at local health departments: a statewide assessment of activities and barriers. J Acquir Immune Defic Syndr. 2018;77(1):72.PubMedPubMedCentralCrossRef
80.
81.
Ojikutu BO, Bogart LM, Higgins-Biddle M, Dale SK, Allen W, Dominique T, et al. Facilitators and barriers to pre-exposure prophylaxis (PrEP) use among black individuals in the United States: results from the National Survey on HIV in the Black Community (NSHBC). AIDS Behav. 2018;22(11):3576–87.PubMedPubMedCentralCrossRef
82.
83.
Goddu AP, O’Conor KJ, Lanzkron S, Saheed MO, Saha S, Peek ME, et al. Do words matter? Stigmatizing language and the transmission of bias in the medical record. J Gen Intern Med. 2018;33(5):685–91.CrossRef
84.
Brooks RA, Landrian A, Nieto O, Fehrenbacher A. Experiences of anticipated and enacted pre-exposure prophylaxis (PrEP) stigma among Latino MSM in Los Angeles. AIDS Behav. 2019;23(7):1964–73.PubMedPubMedCentralCrossRef
85.
Brooks RA, Nieto O, Landrian A, Donohoe TJ. Persistent stigmatizing and negative perceptions of pre-exposure prophylaxis (PrEP) users: implications for PrEP adoption among Latino men who have sex with men. AIDS Care. 2019;31(4):427–35.PubMedCrossRef
86.
Ellorin E, Blumenthal J, Jain S, Sun X, Corado K, Dube M, et al. Frame me if you must: PrEP framing and the impact on adherence to HIV pre-exposure prophylaxis. Open Forum Infect Dis. 2017;4:439.CrossRef
87.
Marcus JL, Katz KA, Krakower DS, Calabrese SK. Risk compensation and clinical decision making—the case of HIV preexposure prophylaxis. N Engl J Med. 2019;380(6):510.PubMedPubMedCentralCrossRef
88.
Philbin MM, Parker CM, Parker RG, Wilson PA, Garcia J, Hirsch JS. Gendered social institutions and preventive healthcare seeking for black men who have sex with men: the promise of biomedical HIV prevention. Arch Sex Behav. 2018;47(7):2091–100.PubMedPubMedCentralCrossRef
89.
Himmelstein MS, Sanchez DT. Masculinity impediments: internalized masculinity contributes to healthcare avoidance in men and women. J Health Psychol. 2016;21(7):1283–92.PubMedCrossRef
90.
Jaiswal J, LoSchiavo C, Maiolatesi A, Kapadia F, Halkitis PN. Misinformation, gendered perceptions, and low healthcare provider communication around HPV and the HPV vaccine among young sexual minority men in New York City: the P18 cohort study. J Community Health. 2020;45:702.PubMedPubMedCentralCrossRef
91.
Griffith DM, Gilbert KL, Bruce MA, Thorpe RJ. Masculinity in men’s health: barrier or portal to healthcare? In: Men’s health in primary care. Cham: Springer; 2016. p. 19–31.CrossRef
92.
93.
Griffin-Tomas M, Cahill S, Kapadia F, Halkitis PN. Access to health services among young adult gay men in New York City. Am J Mens Health. 2019;13(1):1557988318818683.PubMedCrossRef
94.
Jaiswal J, Singer SN, Siegel K, Lekas HM. HIV-related ‘conspiracy beliefs’: lived experiences of racism and socio-economic exclusion among people living with HIV in New York City. Cult Health Sex. 2019;21(4):373–86.PubMedCrossRef
Metadata
Title
Correlates of PrEP Uptake Among Young Sexual Minority Men and Transgender Women in New York City: The Need to Reframe “Risk” Messaging and Normalize Preventative Health
Authors
J. Jaiswal
C. LoSchiavo
S. Meanley
K. Hascher
A. B. Cox
K. B. Dunlap
S. N. Singer
P. N. Halkitis
Publication date
01-10-2021
Publisher
Springer US
Published in
AIDS and Behavior / Issue 10/2021
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-021-03254-4

Other articles of this Issue 10/2021

AIDS and Behavior 10/2021 Go to the issue

Original Paper

Derivation of an HIV Risk Score for African Women Who Engage in Sex Work

Original Paper

“Who are You and What are You Doing Here?”: Social Capital and Barriers to Movement along the HIV Care Cascade among Tajikistani Migrants with HIV to Russia

Original Paper

Living at the Confluence of Stigmas: PrEP Awareness and Feasibility Among People Who Inject Drugs in Two Predominantly Rural States

Original Paper

Depression and Suicidal Behaviors Among HIV-Infected Inmates in Lesotho: Prevalence, Associated Factors and a Moderated Mediation Model

Original Paper

Depression and Viral Suppression Among Adults Living with HIV in Tanzania

Original Paper

Prospective Evaluation of an Abbreviated Test Battery to Screen for Neurocognitive Impairment in HIV-Positive Military Members
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits